Technical Analysis for EXAS - Exact Sciences Corporation

Grade Last Price % Change Price Change
grade D 86.24 3.15% 2.63
EXAS closed up 3.15 percent on Friday, December 6, 2019, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical EXAS trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Weak + Overbought Other 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.15%
Narrow Range Bar Range Contraction 3.15%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.07%
Narrow Range Bar Range Contraction 4.07%
Older signals for EXAS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test includes proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company's stool-based DNA colorectal cancer screening technology also focuses on the inflammatory bowel disease. It has collaboration, license, and purchase agreement with Genzyme Corporation, as well as with Mayo Clinic for developing tests to detect other gastro-intestinal cancers, primarily esophageal and pancreatic cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Medicine Health Cancer Medical Tests Inflammatory Bowel Disease Colorectal Cancer Pancreatic Cancer Cancer Screening Diagnostic Gastroenterology Mayo Clinic Polyp

Is EXAS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 123.99
52 Week Low 53.06
Average Volume 2,129,122
200-Day Moving Average 100.29
50-Day Moving Average 86.94
20-Day Moving Average 81.65
10-Day Moving Average 82.02
Average True Range 3.33
ADX 17.66
+DI 25.42
-DI 21.98
Chandelier Exit (Long, 3 ATRs ) 76.79
Chandelier Exit (Short, 3 ATRs ) 85.35
Upper Bollinger Band 85.89
Lower Bollinger Band 77.41
Percent B (%b) 1.04
BandWidth 10.38
MACD Line -1.12
MACD Signal Line -2.14
MACD Histogram 1.0194
Fundamentals Value
Market Cap 10.27 Billion
Num Shares 119 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -66.85
Price-to-Sales 34.69
Price-to-Book 10.86
PEG Ratio -1.87
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 90.41
Resistance 3 (R3) 90.13 88.46 89.72
Resistance 2 (R2) 88.46 87.40 88.60 89.48
Resistance 1 (R1) 87.35 86.74 87.91 87.63 89.25
Pivot Point 85.68 85.68 85.96 85.82 85.68
Support 1 (S1) 84.57 84.62 85.13 84.85 83.23
Support 2 (S2) 82.90 83.96 83.04 83.00
Support 3 (S3) 81.79 82.90 82.77
Support 4 (S4) 82.07